KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Exelixis (EXEL) EBT Margin (2016 - 2026)

Historic EBT Margin for Exelixis (EXEL) over the last 17 years, with Q1 2026 value amounting to 42.21%.

  • Exelixis' EBT Margin rose 96100.0% to 42.21% in Q1 2026 from the same period last year, while for Jan 2026 it was 40.57%, marking a year-over-year increase of 91400.0%. This contributed to the annual value of 40.57% for FY2026, which is 91400.0% up from last year.
  • According to the latest figures from Q1 2026, Exelixis' EBT Margin is 42.21%, which was up 96100.0% from 42.23% recorded in Q4 2025.
  • Over the past 5 years, Exelixis' EBT Margin peaked at 45.96% during Q2 2024, and registered a low of 7.41% during Q4 2022.
  • For the 5-year period, Exelixis' EBT Margin averaged around 24.8%, with its median value being 23.15% (2022).
  • Over the last 5 years, Exelixis' EBT Margin had its largest YoY gain of 289000bps in 2023, and its largest YoY loss of -211200bps in 2023.
  • Quarter analysis of 5 years shows Exelixis' EBT Margin stood at 7.41% in 2022, then soared by 390bps to 21.48% in 2023, then skyrocketed by 34bps to 28.68% in 2024, then skyrocketed by 47bps to 42.23% in 2025, then decreased by 0bps to 42.21% in 2026.
  • Its EBT Margin was 42.21% in Q1 2026, compared to 42.23% in Q4 2025 and 40.55% in Q3 2025.